6
Potential complications
The side effects subside relatively quickly (after
1-2 weeks).
Potential side effects associated with this treatment
include:
• Petechia,
• Irritation,
• Hematoma,
• Swelling and numbness of the skin over the
treatment area,
• Pain and discomfort during and after treatment
(anesthesia is not necessary),
• Reddening of the skin.
Only if the device is not used properly:
• Potential damage to lung and gut tissue,
• Potential damage to pre-ruptured tendons,
• Potential damage to immature epiphyses,
• Possible dissemination of malignant tumors,
• Potential damage to articular cartilage.
Skin lesions could be observed if patients were pre-treated
with cortisone for a longer time period.
Please make sure that all side effects have sub-
sided before resuming treatment.
1. WARNING
EMS and the distributor of this product accept no liability for direct or consequential injury or damage resulting from
improper use, arising in particular through non-observance of the operating instructions, or improper preparation and
maintenance.
Before using this product, please carefully read,
understand, and follow the recommendations in
the instruction manual. Failure to observe the
operating instructions may result in the patient or
user suffering serious injury or the product being
damaged. This product may only be applied for
its intended use by qualied personnel and for
the applications described in this manual. If the
product is used in combination with other instru-
ments, please refer to their instruction manual.
In case of extended use of more than 6 hours, it is
recommended that the user wear ear protection.
Installation of the unit shall always permit the
ventilation to work properly. Never hide the back
of the unit (with a towel, etc.). Distance from a
wall should be at least 10 cm.
No Modication shall be made on the product.
The device is disconnected from the supply
network when the connector of power cord is
disconnected from the device. The power cord
connector must be accessible at any time.
00_FB-656_10_rev_A_IFU_Dolorclast RSW.indb 600_FB-656_10_rev_A_IFU_Dolorclast RSW.indb 6 25/03/2021 17:0725/03/2021 17:07